• Mothers of Fragile X Children Have Cognitive Problems Linked to Their Genetic Profile and Older Age, Study Finds
  • CONNECT-FX Trial Testing Cannabidiol Gel Zygel in Fragile X Close to Complete Enrollment, Zynerba Announces
  • Results of Phase 2 Trial Testing OV101 in Fragile X Expected Later This Year
  • ICAM5 Protein May Be Target to Treat Cognitive Impairment in Fragile X, Study Suggests
  • Several Proteins Tied to Neuronal Defects May Offer Way of Treating FXTAS, Study Suggests
  • Abnormal Gaze Linked to Social Cognition in Women With FMR1 Premutation, Study Finds
  • Hallmark DNA Repeats Not Tied to Typical Gene Silencing in Fragile X Syndrome, Case Study Suggests
  • New Partners Aim to Accelerate the Discovery and Repurposing of Medicines for Rare Neurological Diseases
  • Gene Therapy Takes Center Stage at 2019 NORD Summit
  • New Method of Analyzing DNA Repeats May Help Diagnose Fragile X and Other Disorders, Study Reports
  • HHS Secretary Alex Azar Touts White House Efforts to Cure Rare Diseases
  • Challenging Behavior in Children with Fragile X Affects Maternal Mental Health and Mother-child Bond, Study Finds